GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Mankind Pharma MANKIND.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

2,668.30

+5.05%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹142.78bn

FY2019FY2026

Net income

₹19.13bn

FY2019FY2026

Free cash flow

₹18.90bn

FY2019FY2026

Shareholders' equity

₹163.00bn

FY2019FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue₹142.78bn₹122.07bn₹102.59bn₹87.49bn₹77.82bn₹62.14bn₹58.65bn₹49.80bn
Research and development—₹2.32bn₹254.5m₹254.5m₹20.4m₹123.7m—₹1.10bn
Operating income₹27.31bn₹29.37bn₹22.39bn₹17.12bn₹20.30bn₹16.06bn₹14.69bn₹8.69bn
Net income₹19.13bn₹19.91bn₹19.13bn₹12.82bn₹14.33bn₹12.65bn₹10.30bn₹5.79bn
Diluted earnings per share46.2748.1747.4931.9535.7830.6124.9213.99

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assets₹280.80bn₹277.60bn₹119.63bn₹97.15bn₹91.48bn₹63.73bn₹50.73bn₹41.12bn
Cash and short-term investments₹20.20bn₹22.45bn₹34.56bn₹15.29bn₹12.79bn₹20.04bn₹10.84bn₹6.84bn
Total liabilities₹115.18bn₹131.91bn₹23.87bn₹20.67bn₹28.31bn₹15.10bn₹14.02bn₹11.31bn
Debt—₹85.11bn₹2.07bn₹1.70bn₹8.84bn₹2.80bn₹1.33bn—
Shareholders' equity₹163.00bn₹143.32bn₹93.63bn₹74.35bn₹61.55bn₹47.22bn₹34.85bn₹28.23bn
Shares outstanding413m413m403m401m401m413m413m413m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations₹25.16bn₹24.13bn₹21.52bn₹18.13bn₹9.20bn₹11.37bn₹10.70bn₹6.00bn
Capital spending−₹6.26bn−₹4.61bn−₹3.82bn−₹8.32bn−₹23.46bn−₹3.12bn−₹2.28bn−₹2.98bn
Free cash flow₹18.90bn₹19.53bn₹17.70bn₹9.81bn−₹14.26bn₹8.25bn₹8.42bn₹3.03bn
Dividends paid−₹412.7m—————−₹3.64bn−₹240.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹40.31bn₹34.43bn₹35.67bn₹36.97bn₹35.70bn₹30.08bn₹31.99bn₹30.61bn
Operating income₹8.30bn₹7.07bn₹6.97bn₹7.00bn₹6.28bn₹5.60bn₹6.29bn₹7.47bn
Net income₹5.68bn₹5.54bn₹4.09bn₹5.12bn₹4.38bn₹4.21bn₹3.80bn₹6.53bn
Diluted earnings per share13.7413.419.8912.3810.6110.189.4416.22
Cash from operations———₹16.37bn————
Capital spending———−₹2.71bn————
Free cash flow———₹13.66bn————
Total assets—₹280.80bn—₹288.13bn—₹277.60bn—₹139.82bn
Cash and short-term investments₹22.08bn₹20.20bn₹34.99bn₹31.05bn₹25.25bn₹22.45bn₹47.27bn₹47.27bn
Debt—₹62.40bn—₹41.60bn—₹84.97bn—₹4.76bn
Shareholders' equity₹165.61bn₹163.00bn₹155.29bn₹152.86bn₹145.68bn₹143.32bn₹107.89bn₹105.65bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue17.7%18.1%—
Operating income16.9%11.2%—
Net income14.3%8.6%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin21.4%21.1%22.3%—
Net margin14.7%15.6%16.5%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023
Price to earnings54.545.660.662.0
Price to sales7.37.411.39.1

Dividends and splits

Per share, in the currency the company pays

Paid for 1 years. Last went ex-dividend on 8 Aug 2025.

FY2026
Paid in the year1.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.